Page 265 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.4. Patient characteristics—age (continued)
Author Database Age groups 1980-84 1985-89 1990-94 1995-99 2000-04 2005- Statistical Notes
Year (yr) 10 analysis
PMID
42
Shao SEER White 72.3 (8.6) 69.5 (12.3) 67.6 -4.7 (P<0.001) Excluding
2009 Black 70.8 (8.9) 67.2 (9.7) (10.0) -6.4 (P<0.001) age <25 yr
19713548 Total 72.2 (8.7) 69.2 (12.0) 64.4 -5.0 (P<0.001)
Mean (1988-89) (1996-97) (10. 0) [absolute
age (SD) 67.2 change
(10.1) between
(2004- 1988-1989
05) and 2004-05
(p-values from
ANOVA with
linear
contrast)]
46
Polednak 2002 SEER <65 4717 (non- 5229 (non-
12477140 Hispanic Hispanic NR Data were
White), 828 White), not
(Black) 1101 reported for
≥65 (Black) patients of
Age at other
diagnosis 18,630 (non- 11,882 racial/ethnic
Hispanic (non- groups.
White), 2141 Hispanic
(Black) White),
(1992) 1720
(Black)
(1997)
50
Severson SEER- 75-79 1079 1265 (50%) 2290 (54%) NR Limited to
1995 Detroit 80-84 (47%) 772 (30%) 1260 (30%) men ≥75 yr
7707440 85-89 739 382 (15%) 533 (13%)
≥90 (32%) 124 (5%) 158 (4%)
Count 378 (1985-88) (1989-1992)
(percentage) (16%)
of patients in 120
each age (5%)
group (1980-
84)

C-50